The University of Sydney Ethics BoardPembrolizumablung cancerDurvalumabNivolumabTranslational Immunology LaboratoryUniversity of Sydney
… not expressing PDL-1.Ethics Approval The study was approved by The University of Sydney Ethics Board, approval number X18-0525 & 2019/ETH08954.Abstract 40 Figure 1K…